Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2708 | JNK-IN-8 | 3.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | IFN-g | 79.0 | 87 | |
N2759 | IL-1 alpha | 100 | ng/mL | 1 | IL-4 | 72.0 | 55 | ||||
RA2708 | PH-797804 | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | IFN-g | 60.0 | 68 | |
RA1869 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | RANTES | 84.0 | 61 | |
N2759 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | RANTES | 425.5 | 58 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | RANTES | 25.0 | 61 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | RANTES | 44.0 | 48 | |
RA1931 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | RANTES | 191.0 | 45 | |
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | RANTES | 5213.0 | 53 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | RANTES | 630.5 | 44 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 1 | RANTES | 6029.0 | 52 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | RANTES | 6069.0 | 39 | |
N2586 | IL-1 alpha | 100 | ng/mL | 1 | RANTES | 12157.0 | 48 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | RANTES | 12879.0 | 61 | |
N2645 | PH-797804 | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL-4 | 34.5 | 60 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 3 | IL-5 | 10.0 | 67 | ||||
N2759 | IL-1 alpha | 100 | ng/mL | 3 | IL-5 | 10.5 | 64 | ||||
RA1931 | IL-1 alpha | 100 | ng/mL | 3 | IL-5 | 10.0 | 73 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 3 | IL-5 | 9.0 | 57 | ||||
RA1869 | JNK-IN-8 | 3.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-5 | 10.0 | 47 | |
RA1869 | PH-797804 | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-5 | 9.0 | 51 | |
N2759 | JNK-IN-8 | 3.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-5 | 10.0 | 67 | |
N2759 | PH-797804 | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-5 | 12.0 | 55 | |
N2645 | IL-1 alpha | 100 | ng/mL | 4 | IL-7 | 22.5 | 70 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL-7 | 21.0 | 59 |